Literature DB >> 10067054

[Drug-induced pneumonitis].

A Kondo1.   

Abstract

Drug can cause various types of lung damages, with drug-induced pneumonitis (including acute interstitial pneumonia, usual interstitial pneumonia, desquamative interstitial pneumonia, nonspecific interstitial pneumonia, bronchiolitis obliterans with organizing pneumonia, eosinophilic pneumonia and hypersensitivity pneumonitis) being the most important among them. The incidence and the causative agents of drug induced pneumonitis have varied over time. Before 1980, anticancer agents and gold salts were the main drugs, and the number of causative drugs (61) and case reports was small. Recently, pneumonitis has increasingly been caused by Chinese herbal medicines, antibiotics, chemotherapy agents, anti-inflammatory drugs, analgesics, cytokines, and gold salts, and the number of case reports and drugs involved (177) has increased. Drug-induced pneumonitis has characteristics that depend on the causative agent. Review of our patients and reports in Japan revealed the following. Pneumonitis caused by anti-inflammatory drugs, analgesics, and antibiotics generally develops at 1-2 weeks after starting administration, and bronchoalveolar lavage and histologic examination of lung biopsies reveals the features of eosinophilic pneumonia. Such pneumonitis is associated with a high frequency of a positive drug lymphocyte stimulation test (DLST), and has a good outcome. Conversely, with pneumonitis caused by anticancer and immunosuppressive agents, the onset is often delayed and the disease has features of diffuse interstitial pneumonia and pulmonary fibrosis. The frequency of a positive DLST is low, and the outcome is generally poor. Pneumonitis induced by Chinese herbal medicines, gold salts, and antituberculosis agents has intermediate features between the above two types :i.e., it develops after 2-3 months or six months (gold salts), and resembles either eosinophilic pneumonia, BOOP or interstitial pneumonia. For in vitro identification of causative drugs, the DLST and the leukocyte migration inhibition test (LMIT) are generally used. The latter test is superior in sensitivity, suggesting that the mechanism of this test involves cytokines such as IL-1 alpha, IL-1 beta, IL-2, TNF-alpha, and IL-8.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067054

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  7 in total

1.  Sequential adjuvant chemoradiotherapy-induced diffuse alveolar haemorrhage in a patient with breast cancer successfully treated with corticosteroid plus recombinant human soluble thrombomodulin.

Authors:  Takamasa Kitajima; Satoshi Marumo; Yurina Maeshima; Motonari Fukui
Journal:  BMJ Case Rep       Date:  2016-10-28

2.  Seasonal Influenza Vaccine-induced Pneumonitis Presenting with Multiple Pulmonary Nodules.

Authors:  Takeshi Numata; Norihito Hida; Kai Yazaki; Naoki Arai; Kyoko Ota; Hidetoshi Yanai; Takeo Endo
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

3.  A case of drug induced lung injury caused by levofloxacin eye drops.

Authors:  Naoki Hosogaya; Kazuhiro Toida; Hiroshi Ishihara; Kiyotaka Kugiyama
Journal:  Respir Med Case Rep       Date:  2018-03-16

4.  Utility of Basophil Activation Test in a Case of Daisaikoto- and Yokukansan-induced Lung Injury.

Authors:  Tomoko Kawahara; Munehiro Yamaguchi; Chisato Onitsuka; Tomoyuki Kimura; Tetsuya Homma; Hironori Sagara
Journal:  Intern Med       Date:  2020-12-22       Impact factor: 1.271

5.  Therapeutic effects of saireito (chai-ling-tang), a traditional Japanese herbal medicine, on lymphedema caused by radiotherapy: a case series study.

Authors:  Aiko Nagai; Yuta Shibamoto; Keiko Ogawa
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

6.  Eribulin-induced Interstitial Pneumonia: A Case Series and Retrospective Cohort Study.

Authors:  Manabu Murakami; Hiroaki Kanemura; Yutaka Tomishima; Eriko Nakano; Tomohide Tamura
Journal:  Intern Med       Date:  2019-10-07       Impact factor: 1.271

7.  Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case-control study.

Authors:  Benedikt Kowalski; Alan Valaperti; Pascal Bezel; Urs C Steiner; Dieter Scholtze; Stephan Wieser; Maya Vonow-Eisenring; Andrea Widmer; Malcolm Kohler; Daniel Franzen
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-04       Impact factor: 4.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.